Found: 5000
Select item for more details and to access through your institution.
Neoadjuvant/Adjuvant Durvalumab for Resectable Non-Small Cell Lung Cancer Gets FDA Nod.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 9, p. 17
- Publication type:
- Article
FDA OKs Lazertinib With Amivantamab-vmjw for Non-Small Cell Lung Cancer.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 9, p. 17
- Publication type:
- Article
Biotin-Functionalized Lipid Nanoparticles: A Promising Approach for Gemcitabine Delivery in Non-Small Cell Lung Cancer Treatment.
- Published in:
- Journal of Young Pharmacists, 2024, v. 16, n. 3, p. 520, doi. 10.5530/jyp.2024.16.66
- By:
- Publication type:
- Article
Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05471-6
- By:
- Publication type:
- Article
circRACGAP1 Promotes Proliferation of Non-Small Cell Lung Cancer Cells through the miR-1296/CDK2 Pathway.
- Published in:
- Folia Biologica (00155500), 2024, v. 70, n. 2, p. 104, doi. 10.14712/fb2024070020104
- By:
- Publication type:
- Article
miR-325 Supresses Cell Proliferation and Migration in Non-Small Cell Lung Cancer via Targeting DNA Ligase 1 (LIG1).
- Published in:
- Folia Biologica (00155500), 2024, v. 70, n. 2, p. 95, doi. 10.14712/fb2024070020095
- By:
- Publication type:
- Article
A real-world pharmacovigilance study of KRAS G12C mutation inhibitors based on the food and drug administration adverse event reporting system.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1418469
- By:
- Publication type:
- Article
PARP1 promotes EGFR-TKI drug-resistance via PI3K/AKT pathway in non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 2, p. 209, doi. 10.1007/s00280-024-04668-2
- By:
- Publication type:
- Article
Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 2, p. 197, doi. 10.1007/s00280-024-04666-4
- By:
- Publication type:
- Article
STAT3 inhibitor Stattic Exhibits the Synergistic Effect with FGFRs Inhibitor Erdafitinib in FGFR1-positive Lung Squamous Cell Carcinoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 16, p. 5415, doi. 10.7150/jca.97477
- By:
- Publication type:
- Article
Study of LY9 as a potential biomarker for prognosis and prediction of immunotherapy efficacy in lung adenocarcinoma.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17816
- By:
- Publication type:
- Article
Alkaloids of Aconiti Lateralis Radix Praeparata inhibit growth of non-small cell lung cancer by regulating PI3K/Akt-mTOR signaling and glycolysis.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06801-6
- By:
- Publication type:
- Article
Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1399613
- By:
- Publication type:
- Article
Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K/AKT/mTOR pathway.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72198-1
- By:
- Publication type:
- Article
GLIDR-mediated regulation of tumor malignancy and cisplatin resistance in non-small cell lung cancer via the miR-342-5p/PPARGC1A axis.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12845-y
- By:
- Publication type:
- Article
Diagnostic value of microRNA-200 expression in peripheral blood-derived extracellular vesicles in early-stage non-small cell lung cancer.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01455-4
- By:
- Publication type:
- Article
The utility of value frameworks in cost communications: making them real for patients.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1411, doi. 10.1093/jnci/djae156
- By:
- Publication type:
- Article
Response to Wu and Zhang.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1532, doi. 10.1093/jnci/djae131
- By:
- Publication type:
- Article
RE: Spatial intratumor heterogeneity of programmed cell death ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1530, doi. 10.1093/jnci/djae130
- By:
- Publication type:
- Article
Clinical utility of repeated rebiopsy for EGFR T790M mutation detection in non-small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1452947
- By:
- Publication type:
- Article
The AST/ALT ratio predicts survival and improves oncological therapy decisions in patients with non-small cell lung cancer receiving immunotherapy with or without radiotherapy.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1389804
- By:
- Publication type:
- Article
Significance of novel PANoptosis genes to predict prognosis and therapy effect in the lung adenocarcinoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-71954-7
- By:
- Publication type:
- Article
Development of a prognostic model for NSCLC based on differential genes in tumour stem cells.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-71317-2
- By:
- Publication type:
- Article
Long-term survival following molecular-targeted therapy for intramedullary non-small-cell lung cancer metastasis.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Impact of interplay effects on spot scanning proton therapy with motion mitigation techniques for lung cancer: SFUD versus robustly optimized IMPT plans utilizing a four-dimensional dynamic dose simulation tool.
- Published in:
- Radiation Oncology, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13014-024-02518-2
- By:
- Publication type:
- Article
Single-cell transcriptomics reveals tumor-infiltrating B cell function after neoadjuvant pembrolizumab and chemotherapy in non-small cell lung cancer.
- Published in:
- Journal of Leukocyte Biology, 2024, v. 116, n. 3, p. 555, doi. 10.1093/jleuko/qiad138
- By:
- Publication type:
- Article
Inhibition of ULK1/2 and KRAS<sup>G12C</sup> controls tumor growth in preclinical models of lung cancer.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.96992
- By:
- Publication type:
- Article
Deoxybouvardin targets EGFR, MET, and AKT signaling to suppress non-small cell lung cancer cells.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-70823-7
- By:
- Publication type:
- Article
Radiomics nomogram for predicting chemo-immunotherapy efficiency in advanced non-small cell lung cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63415-y
- By:
- Publication type:
- Article
Clinical efficacy of Apatinib combined with Epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) in nonsmall cell lung cancer after EGFR-TKI resistance.
- Published in:
- Pakistan Journal of Medical Sciences, 2024, v. 40, n. 8, p. 1714, doi. 10.12669/pjms.40.8.9682
- By:
- Publication type:
- Article
Comparative analysis of the clinical effects of different thoracoscopic resection in the treatment of Stage I Non-Small Cell Lung Cancer.
- Published in:
- Pakistan Journal of Medical Sciences, 2024, v. 40, n. 8, p. 1644, doi. 10.12669/pjms.40.8.9124
- By:
- Publication type:
- Article
Ginsenoside Rg3 targets glycosylation of PD-L1 to enhance anti-tumor immunity in non-small cell lung cancer.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1434078
- By:
- Publication type:
- Article
SH003 Induces DR5-Mediated Caspase-Dependent Apoptosis of NSCLC Through Inhibition of AKT Survival Pathway.
- Published in:
- Natural Product Communications, 2024, v. 19, n. 8, p. 1, doi. 10.1177/1934578X241265216
- By:
- Publication type:
- Article
Correlation of TNF-α polymorphisms with susceptibility to lung cancer: evidence from a meta-analysis based on 29 studies.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12854-x
- By:
- Publication type:
- Article
AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1444007
- By:
- Publication type:
- Article
Applications of CT-based radiomics for the prediction of immune checkpoint markers and immunotherapeutic outcomes in non-small cell lung cancer.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1434171
- By:
- Publication type:
- Article
Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy.
- Published in:
- Journal of Nanobiotechnology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12951-024-02828-3
- By:
- Publication type:
- Article
Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrence.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03800-8
- By:
- Publication type:
- Article
Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03797-0
- By:
- Publication type:
- Article
Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03792-5
- By:
- Publication type:
- Article
Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03781-8
- By:
- Publication type:
- Article
Immune checkpoint inhibitors with or without radiotherapy in metastatic non‑small cell lung cancer: A meta‑analysis and literature review.
- Published in:
- Oncology Letters, 2024, v. 28, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14622
- By:
- Publication type:
- Article
Pembrolizumab therapy in a patient with NSCLC and bullous pemphigoid: A case report.
- Published in:
- Oncology Letters, 2024, v. 28, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14603
- By:
- Publication type:
- Article
Atractyloside inhibits gefitinib‑resistant non‑small‑cell lung cancer cell proliferation.
- Published in:
- Oncology Letters, 2024, v. 28, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14599
- By:
- Publication type:
- Article
Mucosa‑associated lymphoid tissue lymphoma translocation protein 1 inhibitor, MI‑2, attenuates non‑small cell lung cancer cell proliferation, migration and invasion, and promotes apoptosis by suppressing the JNK/c‑JUN pathway.
- Published in:
- Oncology Letters, 2024, v. 28, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14598
- By:
- Publication type:
- Article
Assessing the Quality of Life of Metastatic Non-Small Cell Lung Cancer Patients after Chemotherapy: An Assessment Which Tells What's Next.
- Published in:
- Tanaffos, 2023, v. 22, n. 4, p. 349
- By:
- Publication type:
- Article
Prevalence and treatment of human epidermal growth factor receptor 2-altered non-small cell lung cancer: a retrospective analysis and systematic literature review.
- Published in:
- Ecancermedicalscience, 2024, v. 18, n. 1676-1753, p. 1, doi. 10.3332/ecancer.2024.1734
- By:
- Publication type:
- Article
Reduced frequency dosing of osimertinib in EGFR-mutant non-small cell lung carcinoma: real world data.
- Published in:
- Ecancermedicalscience, 2024, v. 18, n. 1676-1753, p. 1, doi. 10.3332/ecancer.2024.1721
- By:
- Publication type:
- Article
Thyroid autoantibodies at baseline predict longer survival in non-small cell lung cancer patients treated with anti-programmed cell death-1 blockade: a prospective study.
- Published in:
- Nagoya Journal of Medical Science, 2024, v. 86, n. 3, p. 452, doi. 10.18999/nagjms.86.3.452
- By:
- Publication type:
- Article
Regulatory mechanism of lncRNA miR143HG in miR-504 and its effect on proliferation and apoptosis of non-small cell lung cancer cells.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2024, v. 23, n. 8, p. 1231, doi. 10.4314/tjpr.v23i8.1
- By:
- Publication type:
- Article